First Light Asset Management as of Sept. 30, 2014
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 62 positions in its portfolio as reported in the September 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
NeoGenomics (NEO) | 8.9 | $13M | 2.5M | 5.21 | |
IGI Laboratories | 7.8 | $11M | 1.2M | 9.32 | |
Spectranetics Corporation | 5.3 | $7.8M | 292k | 26.57 | |
Akorn | 5.3 | $7.7M | 214k | 36.27 | |
AtriCure (ATRC) | 5.0 | $7.3M | 497k | 14.72 | |
RTI Biologics | 4.4 | $6.4M | 1.3M | 4.78 | |
Enzo Biochem (ENZ) | 4.0 | $5.9M | 1.1M | 5.15 | |
NxStage Medical | 3.1 | $4.5M | 346k | 13.13 | |
Harvard Bioscience (HBIO) | 3.0 | $4.4M | 1.1M | 4.09 | |
Streamline Health Solutions (STRM) | 2.7 | $3.9M | 846k | 4.63 | |
Array BioPharma | 2.6 | $3.8M | 1.1M | 3.57 | |
Ligand Pharmaceuticals In (LGND) | 2.5 | $3.6M | 76k | 46.98 | |
Quidel Corporation | 2.4 | $3.6M | 133k | 26.87 | |
Techne Corporation | 2.3 | $3.4M | 37k | 93.56 | |
Spectrum Pharmaceuticals | 2.1 | $3.1M | 379k | 8.14 | |
Tearlab Corp | 2.1 | $3.0M | 897k | 3.40 | |
Omnicell (OMCL) | 2.1 | $3.0M | 111k | 27.33 | |
STAAR Surgical Company (STAA) | 2.1 | $3.0M | 285k | 10.63 | |
Oxford Immunotec Global | 2.0 | $2.9M | 190k | 15.27 | |
Sanofi-Aventis SA (SNY) | 1.9 | $2.8M | 50k | 56.43 | |
Alkermes (ALKS) | 1.9 | $2.8M | 65k | 42.87 | |
Novadaq Technologies | 1.8 | $2.6M | 208k | 12.69 | |
Endologix | 1.7 | $2.5M | 232k | 10.60 | |
Sagent Pharmaceuticals | 1.5 | $2.2M | 71k | 31.10 | |
Lannett Company | 1.3 | $1.9M | 43k | 45.69 | |
Celldex Therapeutics | 1.3 | $1.9M | 143k | 12.96 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $1.8M | 16k | 112.31 | |
HealthStream (HSTM) | 1.2 | $1.8M | 76k | 24.01 | |
D Fluidigm Corp Del (LAB) | 1.2 | $1.8M | 75k | 24.50 | |
Cepheid | 1.2 | $1.8M | 41k | 44.03 | |
Align Technology (ALGN) | 1.2 | $1.8M | 34k | 51.69 | |
Advisory Board Company | 1.1 | $1.7M | 36k | 46.60 | |
LeMaitre Vascular (LMAT) | 1.1 | $1.7M | 243k | 6.88 | |
Sunopta (STKL) | 1.0 | $1.5M | 123k | 12.07 | |
BioMarin Pharmaceutical (BMRN) | 1.0 | $1.5M | 20k | 72.18 | |
ISIS Pharmaceuticals | 0.7 | $1.1M | 27k | 38.84 | |
AngioDynamics (ANGO) | 0.7 | $958k | 70k | 13.72 | |
Cytokinetics (CYTK) | 0.4 | $581k | 165k | 3.52 | |
Novartis (NVS) | 0.4 | $571k | 6.1k | 94.07 | |
Endo International (ENDPQ) | 0.4 | $558k | 8.2k | 68.37 | |
Aratana Therapeutics | 0.4 | $539k | 54k | 10.04 | |
WellPoint | 0.3 | $490k | 4.1k | 119.66 | |
United Therapeutics Corporation (UTHR) | 0.3 | $491k | 3.8k | 128.53 | |
Actavis | 0.3 | $491k | 2.0k | 241.28 | |
Humana (HUM) | 0.3 | $461k | 3.5k | 130.23 | |
Mylan | 0.3 | $445k | 9.8k | 45.52 | |
Bristol Myers Squibb (BMY) | 0.3 | $424k | 8.3k | 51.15 | |
Aetna | 0.3 | $422k | 5.2k | 80.92 | |
Johnson & Johnson (JNJ) | 0.3 | $407k | 3.8k | 106.54 | |
AstraZeneca (AZN) | 0.3 | $406k | 5.7k | 71.48 | |
Celgene Corporation | 0.3 | $406k | 4.3k | 94.86 | |
Merck & Co (MRK) | 0.3 | $392k | 6.6k | 59.30 | |
St. Jude Medical | 0.2 | $364k | 6.1k | 60.12 | |
Eli Lilly & Co. (LLY) | 0.2 | $356k | 5.5k | 64.79 | |
CareFusion Corporation | 0.2 | $350k | 7.7k | 45.28 | |
Steris Corporation | 0.2 | $342k | 6.3k | 54.03 | |
Community Health Systems (CYH) | 0.2 | $337k | 6.1k | 54.84 | |
Becton, Dickinson and (BDX) | 0.2 | $318k | 2.8k | 113.77 | |
Amgen (AMGN) | 0.2 | $327k | 2.3k | 140.34 | |
Pfizer (PFE) | 0.2 | $311k | 11k | 29.56 | |
Myriad Genetics (MYGN) | 0.2 | $302k | 7.8k | 38.62 | |
Agilent Technologies Inc C ommon (A) | 0.2 | $292k | 5.1k | 57.03 |